0000950170-24-132911.txt : 20241203 0000950170-24-132911.hdr.sgml : 20241203 20241203174003 ACCESSION NUMBER: 0000950170-24-132911 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20241202 FILED AS OF DATE: 20241203 DATE AS OF CHANGE: 20241203 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kenkare-Mitra Sara CENTRAL INDEX KEY: 0001895592 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38792 FILM NUMBER: 241523929 MAIL ADDRESS: STREET 1: C/O ALECTOR, INC STREET 2: 131 OYSTER POINT BLVD, SUITE 600 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Alector, Inc. CENTRAL INDEX KEY: 0001653087 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 822933343 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 131 OYSTER POINT BLVD., SUITE 600 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 415-231-5660 MAIL ADDRESS: STREET 1: 131 OYSTER POINT BLVD., SUITE 600 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: Alector LLC DATE OF NAME CHANGE: 20150915 4 1 ownership.xml 4 X0508 4 2024-12-02 0001653087 Alector, Inc. ALEC 0001895592 Kenkare-Mitra Sara C/O ALECTOR, INC. 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080 false true false false President and Head of R&D false Common Stock 2024-12-02 4 S false 26500 2.5194 D 565215 D The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.5193 to $2.5194. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the issuer, or any security holder of the issuer upon request. /s/ Marc Grasso, by power of attorney 2024-12-03